Spyre Therapeutics
SYRE
#2075
Rank
โ‚น822.52 B
Marketcap
โ‚น8,661
Share price
-4.26%
Change (1 day)
298.48%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2026 (TTM): -โ‚น30.1 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น20.35 Billion a decrease over its 2024 earnings that were of -โ‚น19.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น30.1 Billion47.92%
2025 -โ‚น20.35 Billion5.27%
2024 -โ‚น19.33 Billion62.23%
2023 -โ‚น11.92 Billion51.64%
2022 -โ‚น7.86 Billion29.14%
2021 -โ‚น6.09 Billion-19.43%
2020 -โ‚น7.56 Billion1.43%
2019 -โ‚น7.45 Billion76.7%
2018 -โ‚น4.22 Billion64.27%
2017 -โ‚น2.57 Billion26.34%
2016 -โ‚น2.03 Billion93.6%
2015 -โ‚น1.05 Billion27.08%
2014 -โ‚น0.83 Billion